Bioimpedance in CKD: an untapped resource?

Podobné jednotky

• Bioimpedance indices of fluid overload and cardiorenal outcomes in heart failure and chronic kidney disease: a systematic review
  Autor: Mayne, KJ, a další
  Vydáno: (2022)
• In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes
  Autor: Mayne, KJ, a další
  Vydáno: (2022)
• Impact of primary kidney disease on the effects of empagliflozin in patients with CKD
  Autor: Judge, PK, a další
  Vydáno: (2023)
• In HF, T2D, CKD, or atherosclerotic CVD, SGLT2 inhibitors reduce HF hospitalizations and CV mortality
  Autor: Zhu, D, a další
  Vydáno: (2024)
• Effects of sodium-glucose cotransporter 2 inhibitors on cause-specific cardiovascular death in patients with CKD
  Autor: Fletcher, RA, a další
  Vydáno: (2024)